Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/15/2025

Nifedipine Use in Pregnancy

Introduction to Nifedipine

  • Nifedipine does not appear to interfere with oocyte maturation based on available clinical evidence, and it is considered a safe medication during pregnancy with no documented adverse effects on reproductive outcomes, according to the European Heart Journal and Circulation 1, 2

Mechanism of Action and Safety

  • Nifedipine has been extensively studied in pregnancy and is considered a first-line antihypertensive medication during pregnancy, as stated by Circulation 2
  • It has no documented teratogenic effects when used in pregnant women, as reported by the European Heart Journal 1
  • The European Society of Cardiology lists nifedipine as a safe option for hypertension management in pregnancy, with guidelines published in the European Heart Journal 3

Formulation and Administration

  • Long-acting formulations of nifedipine are preferred for maintenance therapy during pregnancy, while short-acting formulations are reserved for rapid treatment of severe hypertension, according to Circulation 2

Potential Side Effects and Contraindications

  • Maternal side effects of nifedipine include headache, flushing, and reflex tachycardia, as reported by the European Heart Journal 3
  • Fetal side effects include a risk of distress secondary to abrupt maternal hypotension, although this is rare when properly dosed, as stated by the European Heart Journal 3
  • Contraindications for nifedipine use include uncontrolled hypotension and caution when combined with magnesium sulfate, as noted by the European Heart Journal 3

Clinical Recommendations

  • The European Society of Cardiology and European Society of Hypertension position papers consistently recommend nifedipine as a medication for hypertension management during pregnancy, indicating its safety and efficacy, as reported by the European Heart Journal and Circulation 2, 3